Literature DB >> 33317029

U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing.

Namjeong Choi1, Yongchao Liu1, Jagyeong Oh1, Jiyeon Ha1, Xuexiu Zheng1, Haihong Shen1.   

Abstract

Splicing factor 3b subunit 1 (SF3B1) is an essential protein in spliceosomes and mutated frequently in many cancers. While roles of SF3B1 in single intron splicing and roles of its cancer-linked mutant in aberrant splicing have been identified to some extent, regulatory functions of wild-type SF3B1 in alternative splicing (AS) are not well-understood yet. Here, we applied RNA sequencing (RNA-seq) to analyze genome-wide AS in SF3B1 knockdown (KD) cells and to identify a large number of skipped exons (SEs), with a considerable number of alternative 5' splice-site selection, alternative 3' splice-site selection, mutually exclusive exons (MXE), and retention of introns (RI). Among altered SEs by SF3B1 KD, survival motor neuron 2 (SMN2) pre-mRNA exon 7 splicing was a regulatory target of SF3B1. RT-PCR analysis of SMN exon 7 splicing in SF3B1 KD or overexpressed HCT116, SH-SY5Y, HEK293T, and spinal muscular atrophy (SMA) patient cells validated the results. A deletion mutation demonstrated that the U2 snRNP auxiliary factor 65 kDa (U2AF65) interaction domain of SF3B1 was required for its function in SMN exon 7 splicing. In addition, mutations to lower the score of the polypyrimidine tract (PPT) of exon 7, resulting in lower affinity for U2AF65, were not able to support SF3B1 function, suggesting the importance of U2AF65 in SF3B1 function. Furthermore, the PPT of exon 7 with higher affinity to U2AF65 than exon 8 showed significantly stronger interactions with SF3B1. Collectively, our results revealed SF3B1 function in SMN alternative splicing.

Entities:  

Keywords:  SF3B1; SMN; alternative splicing; spinal muscular atrophy

Mesh:

Substances:

Year:  2020        PMID: 33317029      PMCID: PMC7762998          DOI: 10.3390/cells9122647

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  59 in total

Review 1.  The alternative splicing side of cancer.

Authors:  Giuseppe Biamonti; Morena Catillo; Daniela Pignataro; Alessandra Montecucco; Claudia Ghigna
Journal:  Semin Cell Dev Biol       Date:  2014-03-19       Impact factor: 7.727

2.  Three recognition events at the branch-site adenine.

Authors:  C C Query; S A Strobel; P A Sharp
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

Review 3.  The neurobiology of childhood spinal muscular atrophy.

Authors:  T O Crawford; C A Pardo
Journal:  Neurobiol Dis       Date:  1996-04       Impact factor: 5.996

4.  Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.

Authors:  Jian Zhang; Abdullah M Ali; Yen K Lieu; Zhaoqi Liu; Jianchao Gao; Raul Rabadan; Azra Raza; Siddhartha Mukherjee; James L Manley
Journal:  Mol Cell       Date:  2019-08-29       Impact factor: 17.970

5.  The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy.

Authors:  Simona Pedrotti; Pamela Bielli; Maria Paola Paronetto; Fabiola Ciccosanti; Gian Maria Fimia; Stefan Stamm; James L Manley; Claudio Sette
Journal:  EMBO J       Date:  2010-02-25       Impact factor: 11.598

6.  A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy.

Authors:  Xingxing Wu; Shu-Huei Wang; Junjie Sun; Adrian R Krainer; Yimin Hua; Thomas W Prior
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

7.  A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.

Authors:  Tsuyoshi Kashima; James L Manley
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

8.  A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes.

Authors:  Natalia N Singh; Joonbae Seo; Sarah J Rahn; Ravindra N Singh
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

9.  Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.

Authors:  Samar Alsafadi; Alexandre Houy; Aude Battistella; Tatiana Popova; Michel Wassef; Emilie Henry; Franck Tirode; Angelos Constantinou; Sophie Piperno-Neumann; Sergio Roman-Roman; Martin Dutertre; Marc-Henri Stern
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 17.694

10.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.

Authors:  J William Harbour; Elisha D O Roberson; Hima Anbunathan; Michael D Onken; Lori A Worley; Anne M Bowcock
Journal:  Nat Genet       Date:  2013-01-13       Impact factor: 38.330

View more
  3 in total

1.  An Unusual U2AF2 Inhibits Splicing and Attenuates the Virulence of the Human Protozoan Parasite Entamoeba histolytica.

Authors:  Gretter González-Blanco; Guillermina García-Rivera; Patricia Talmás-Rohana; Ester Orozco; José Manuel Galindo-Rosales; Cristina Vélez; Odila Salucedo-Cárdenas; Elisa Azuara-Liceaga; Mario Alberto Rodríguez-Rodríguez; Tomoyoshi Nozaki; Jesús Valdés
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

2.  Identification of the TSSK4 Alternative Spliceosomes and Analysis of the Function of the TSSK4 Protein in Yak (Bos grunniens).

Authors:  Xingdong Wang; Jie Pei; Lin Xiong; Shaoke Guo; Mengli Cao; Yandong Kang; Pengjia Bao; Xiaoyun Wu; Min Chu; Chunnian Liang; Ping Yan; Xian Guo
Journal:  Animals (Basel)       Date:  2022-05-27       Impact factor: 3.231

3.  SRSF6 Regulates the Alternative Splicing of the Apoptotic Fas Gene by Targeting a Novel RNA Sequence.

Authors:  Namjeong Choi; Ha Na Jang; Jagyeong Oh; Jiyeon Ha; Hyungbin Park; Xuexiu Zheng; Sunjae Lee; Haihong Shen
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.